Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticancer drugs: How to select small molecule combinations?

Trends in Pharmacological Sciences(2024)10.1016/j.tips.2024.04.012Source: DataRank Database

Anticancer drugs: How to select small molecule combinations? is a research paper published in Trends in Pharmacological Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

Linked data & code

doi pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 5.23)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Bengi Ruken Yavuz ORCID,Hyunbum Jang ORCID,Ruth Nussinov ORCID

Live enrichment

PubMed:38782689 PMC:PMC11162304 OpenAlex:https://openalex.org/W4398224376

National Cancer Institute

Grant: HHSN261201500003I

NCI NIH HHS

Grant: HHSN261201500003C

Intramural NIH HHS

Grant: Z01 BC010441

Intramural NIH HHS

Grant: Z01 BC010440

U.S. Department of Health and Human Services

Government of the United Kingdom

Center for Cancer Research

National Institutes of Health

FWCI

5.23

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11162304/pdf/nihms-1996701.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0165614724000920?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165614724000920?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11162304

Fields of Study

Cancer-related Molecular PathwaysChronic Myeloid Leukemia TreatmentsLung Cancer Treatments and MutationsMedicineChemistryHumansNeoplasmsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsAnimalsSmall Molecule LibrariesDrug Resistance, Neoplasm

MeSH Terms

AnimalsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsHumansNeoplasmsDrug Resistance, NeoplasmSmall Molecule Libraries

Keywords

PharmacologyMedicinePsychologyComputational biologyBiologydrug combinationsPathway CrosstalkAnticancer Therapies

Sustainable Development Goals

SDG 0: Good health and well-being

Anticancer drugs: How to select small molecule combinations?

FAIR Checklist

Authors (3)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)